Skip to main content
An official website of the United States government
Email

NCI at SRNT Virtual Annual Meeting 2021

The National Cancer Institute (NCI) will be participating in the Society for Research on Nicotine and Tobacco (SRNT) Virtual Annual Meeting, February 24-27.

Registration for the SRNT Virtual Meeting is available at varying rates. Those registered can visit NCI’s virtual exhibit booth at the event.

SRNT Sessions Featuring NCI Experts

Symposium Session Title NCI Participant(s) Date and Time

SYM12, Part of On-Demand Track 8: Hospital and Outpatient Tobacco Treatment Programs in the United States: Models and Associated Health Outcomes 

Stephanie Land

Pre-recorded session released: February 25 at 5:00 PM EST

Live Q+A session 6: February 27 from 10:00-11:30 AM EST
 

All poster sessions will be held February 24 from 11:30 AM – 12:30 PM EST

Poster Session Title NCI Participant(s)

PH-205: State-specific prevalence of tobacco product use among U.S. women, TUS-CPS 2018-2019 

Carolyn Reyes-Guzman

PH-268: Characteristics of U.S. Adults by Cigarette Smoking Status, Housing Type, and Tenure — United States, 2019

Robert Vollinger
Carolyn Reyes-Guzman
 

PH-217: A Test of Two E-Cigarette Use Frequency Measures Using the U.S. Health Information National Trends Survey 5 Cycle 3 Data

Irina Iles
Rachel Grana Mayne (co-author)
 

PH-139: Associations Between Absolute and Relative E-Cigarette Harm Perceptions and Information Seeking Behaviors Among U.S. Adult Current, Former, and Never Smokers 

Irina Iles
Annette Kaufman (co-author)
 

PH-267: A Comparison of Three Different Frequency Measures of Nicotine Delivery Products 

Stephanie Land

NCI Programs and Initiatives 

Learn about some of the tobacco control and cessation programs and initiatives highlighted at the conference, including:

Cancer Grand Challenges - E-cigarette Use

The National Cancer Institute (NCI) and Cancer Research UK (CRUK), the world's leading funders of cancer research, have partnered to fund the Cancer Grand Challenges program. Cancer Grand Challenges will fund novel ideas by multidisciplinary research teams from around the world that offer the potential to advance bold cancer research and improve outcomes for people affected by cancer.

One of the areas of emphasis for the current challenges is to determine the potential benefits and risks of e-cigarette use. Crucial questions that could be addressed include how do e-cigarettes influence overall tobacco use, including initiation, dual use, and cessation, the short and long-term health consequences of e-cigarette use, and how the regulatory context affect the extent of harms and potential benefits of these products.

Apply for this challenge opportunity by April 22, 2021.

Cancer Moonshot - Cancer Center Cessation Initiative

In 2017, NCI launched the Cancer Center Cessation Initiative, as part of the NCI Cancer Moonshot℠ program. The long-term goal of this Initiative is to help cancer centers build and implement sustainable tobacco cessation treatment programs to routinely address tobacco cessation with cancer patients. A list of funded initiatives and publications about the efforts at these cancer centers are available on the website.

NCI’s Tobacco Control Research Branch

At the booth, leave your card for NCI’s Tobacco Control Research Branch (TCRB), which leads and collaborates on research and disseminates evidence-based findings to prevent, treat, and control tobacco use in order to create a world free of tobacco use and related cancer and suffering. TCRB is within the NCI’s Behavioral Research Program (BRP), in the Division of Cancer Control and Population Sciences (DCCPS). 

View the TCRB Fact Sheet to learn more about the branch’s mission, major research initiatives, projects, and smoking cessation resources. 

Resources from TCRB include:

  

  • Posted:

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “NCI at SRNT Virtual Annual Meeting 2021 was originally published by the National Cancer Institute.”

Email